US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 1.3900
- -0.1500-9.74%
Close Apr 19 16:00 ET
- 1.4400
- +0.0500+3.60%
Post 16:54 ET
2.70MMarket Cap-6P/E (TTM)
1.5800High1.3500Low457.03KVolume1.4800Open1.5400Pre Close665.30KTurnover23.49%Turnover RatioLossP/E (Static)1.95MShares442.480052wk High-0.60P/B2.70MFloat Cap1.280052wk Low--Dividend TTM1.95MShs Float509600.0000Historical High--Div YieldTTM14.94%Amplitude1.2800Historical Low1.4550Avg Price1Lot Size
About Allarity Therapeutics Company
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
Company Profile
SymbolALLR
Company NameAllarity Therapeutics
Listing DateDec 21, 2021
Founded2021
CEOMr. Thomas H. Jensen
MarketNASDAQ
Employees6
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address24 School Street,2nd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02108
Phone1-401-426-4664
Websitehttp://www.allarity.com
Company Executives
- Name
- Position
- Salary
- Thomas H. Jensen
- Chief Executive Officer and Director
- --
- Dr. Steen Knudsen, PhD
- Chief Scientific Officer
- --
- Joan Y. Brown
- Director of Financial Reporting, Chief Financial Officer and Principal Accounting Officer
- 180.00K
- Gerald McLaughlin
- Chairman of the Board
- 37.80K
- Joseph Vazzano, C.P.A.
- Independent Director
- --
- Dr. Laura Benjamin, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg